Eli Lilly’s Foundayo Pill Shows Strong Results in Sleep Apnea Trial, Opening Potential $23 Billion Market

Foundayo cut breathing interruptions by as much as 43.8% in a late-stage sleep apnea trial, supporting a new major market for Lilly.